Laboratory Corporation of America Holdings
NYSE:LH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Laboratory Corporation of America Holdings
Other Equity
Laboratory Corporation of America Holdings
Other Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Other Equity
-$27.6m
|
CAGR 3-Years
62%
|
CAGR 5-Years
30%
|
CAGR 10-Years
21%
|
|
|
DaVita Inc
NYSE:DVA
|
Other Equity
-$122.8m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-7%
|
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Other Equity
-$27m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
3%
|
|
|
CVS Health Corp
NYSE:CVS
|
Other Equity
$200m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
Cigna Corp
NYSE:CI
|
Other Equity
-$2.8B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
-8%
|
|
|
Guardant Health Inc
NASDAQ:GH
|
Other Equity
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Laboratory Corporation of America Holdings
Glance View
Laboratory Corporation of America Holdings, commonly known as LabCorp, stands as a formidable player in the world of healthcare diagnostics. Emerging from a confluence of scientific innovation and business acumen, LabCorp has carved a niche within the intricate fabric of healthcare services. Since its inception, the company has excelled in offering a comprehensive suite of laboratory-based tests and services, empowering physicians and healthcare providers with critical insights needed for effective patient diagnosis and management. With its headquarters in Burlington, North Carolina, LabCorp operates a vast network of laboratories and patient service centers across the nation, providing services that range from routine blood work to sophisticated genomic testing. The essence of LabCorp’s business model lies in seamless integration across the healthcare continuum, driving both operational efficiency and profitability. Fundamentally, the company generates revenue by performing diagnostic tests on patient specimens, serving hospitals, managed care organizations, physician offices, and governmental agencies. As healthcare systems evolve towards precision medicine, LabCorp has harnessed emerging technologies and innovations like genomic testing to enhance its service offerings. This expansion not only aligns with changing healthcare paradigms but also fortifies its market leadership. By continually investing in research and development, LabCorp keeps its services at the cutting edge, ensuring steady growth and resilience in an ever-changing healthcare landscape.
See Also
What is Laboratory Corporation of America Holdings's Other Equity?
Other Equity
-27.6m
USD
Based on the financial report for Dec 31, 2025, Laboratory Corporation of America Holdings's Other Equity amounts to -27.6m USD.
What is Laboratory Corporation of America Holdings's Other Equity growth rate?
Other Equity CAGR 10Y
21%
Over the last year, the Other Equity growth was 89%. The average annual Other Equity growth rates for Laboratory Corporation of America Holdings have been 62% over the past three years , 30% over the past five years , and 21% over the past ten years .